Strontium

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: bones joints pain

Research Overview

Current strontium research is most developed in two intersecting areas: (1) osteoporosis pharmacotherapy—primarily strontium ranelate and the cellular signaling mechanisms of strontium ions in bone—and (2) biomaterials and bone tissue engineering, where strontium is substituted for calcium in hydroxyapatite, ceramics, and bioactive glasses to enhance osteogenic performance. Mechanistic studies emphasize strontium’s calcium-mimetic behavior and its engagement of the calcium-sensing receptor (CaSR) in osteoblasts and osteoclasts, with downstream signaling (e.g., PLCβ/IP3/Ca2+ mobilization, ERK1/2 MAPK, and Wnt/NFATc pathways) that modulates osteoclast-regulating factors such as RANKL and OPG and supports osteoblast replication, differentiation, and survival. A separate, well-defined environmental literature examines stable and radioactive strontium (radiostrontium) uptake by plants, its mobility in soils, transfer into the food chain, and implications for risk assessment and phytoremediation.

The strongest evidence supports a dual (often described as “uncoupling” or multidirectional) effect of strontium on bone metabolism: reduced bone resorption with maintained or increased bone formation, demonstrated in preclinical models and supported by clinical evidence for strontium ranelate in osteoporotic patients. In materials science, multiple studies indicate that incorporating strontium into bone-replacement matrices can improve biological performance (e.g., osteoblast viability/osteogenic potential) and can be combined with other therapeutic ions (e.g., copper for antibacterial activity) to achieve staged release profiles and multifunctional scaffolds. In environmental contexts, evidence is strong that plant uptake depends on soil chemistry (including pH), microbial networks, and shared transport pathways with calcium/potassium, enabling both hazard evaluation for edible crops and potential use of plants for radiostrontium removal in contaminated sites.

Key gaps remain in translating strontium-based approaches into optimized, safe, and context-specific interventions. For osteoporosis, further work is needed to refine patient selection, dosing strategies, and long-term safety/benefit profiles across populations and comorbidities, and to clarify how signaling effects vary by cell type, exposure level, and strontium formulation. For biomaterials, more comparative in vivo studies and clinical trials are needed to link strontium release kinetics and substitution levels to functional outcomes (bone regeneration quality, implant integration, infection control) and to standardize evaluation across material platforms. In environmental research, additional field-scale studies are needed to better predict radiostrontium transfer under diverse agricultural practices and climates, and to validate phytoremediation/rhizofiltration performance while managing food-chain risks.

1. What conditions has Strontium been studied for?

  • Osteoporosis / age-related bone loss (especially postmenopausal osteoporosis): Multiple studies focus on strontium ranelate (and strontium ions) as an anti-osteoporosis therapy with effects on bone remodeling and fracture risk.

  • Bone fracture healing / bone defects and bone tissue engineering: Strontium ions are studied as substitutions in ceramics (e.g., strontium-substituted hydroxyapatite) and bioactive glass to support osteogenesis and biomaterial performance.

  • Dental applications:

    • Dentine hypersensitivity (DH): Strontium-containing toothpastes were evaluated in a large meta-analysis of RCTs.

    • Dental scaffolds/coatings: SrO-doped bioglass was studied for cell viability and antibacterial effects relevant to dental materials.

  • Osteoarthritis (temporomandibular joint osteoarthritis, TMJOA): One abstract describes strontium pretreatment of synovial mesenchymal stem cells to improve exosome yield and miRNA profiles for potential OA therapy.

  • Non-communicable diseases (associative/putative roles): A review discusses potential relevance to cardiovascular diseases, hypertension, and diabetes mellitus, largely as a broad overview rather than definitive clinical proof.

  • Environmental/radiological health context (radiostrontium): A review addresses radiostrontium uptake in plants and implications for the food chain and human/environmental risk (not a therapeutic use, but a health-relevant exposure topic).

2. Does it work in treating those conditions? Summarize the evidence.

  • Osteoporosis (strontium ranelate): The studies consistently describe evidence from preclinical and clinical studies that strontium ranelate improves bone mass and resistance and reduces fracture risk in postmenopausal osteoporotic patients. Mechanistically, it is described as having a “multidirectional” effect—reducing bone resorption while maintaining or increasing bone formation—via signaling pathways including CaSR-related cascades and downstream regulators such as RANKL/OPG.

    Limitations noted in the studies: One review explicitly states that how strontium ranelate improves bone strength in humans remains debated, indicating uncertainty about the full mechanism and/or interpretation of some outcomes.

  • Bone repair / tissue engineering materials: Evidence in the studies is mainly materials science + in vitro cell work (e.g., osteoblast cell line viability, bioactivity in simulated body fluid, controlled ion release). These studies support plausibility that strontium-containing biomaterials can promote osteogenic responses and improve material properties, but they are not the same as demonstrating clinical efficacy in humans.

  • Dentine hypersensitivity (strontium toothpastes): A meta-analysis of 53 RCTs (n=4796) found that desensitizing toothpastes generally outperformed controls, but strontium-containing toothpastes were an exception—the analysis “does not advise” their use for DH, and the evidence quality for strontium-containing formulations was described as low.

  • TMJ osteoarthritis (exosome approach): The study describes an experimental strategy where strontium pretreatment improved exosome yield and miRNA profiles in synovial MSC-derived exosomes. This is early-stage evidence (mechanistic/bioprocessing and likely preclinical), not proof of clinical benefit.

  • Cardiometabolic conditions (hypertension/diabetes/CVD): The relevant abstract is a broad review suggesting potential benefits (e.g., antioxidant and anti-inflammatory effects) but also emphasizes that research is not exhaustive and calls for more comprehensive studies. Based on these studies alone, efficacy for these conditions is not established.

3. What health benefits does it have?

  • Bone metabolism benefits (best-supported in these studies):

    • Dual action on remodeling: Strontium (notably as strontium ranelate) is described as both inhibiting osteoclastogenesis/bone resorption and supporting osteoblastogenesis/bone formation.

    • Improved bone outcomes in osteoporosis: Reviews cite evidence of improved bone mass, microarchitecture/strength and reduced fracture risk in postmenopausal osteoporotic patients (for strontium ranelate).

    • Mechanistic pathways: Activation of CaSR and downstream signaling (PLCβ/IP3/Ca2+, ERK1/2, Wnt/NFATc) with modulation of RANKL/OPG and osteoblast survival/differentiation genes is described.

  • Potential benefits in biomaterials (supportive but mostly preclinical/in vitro):

    • Osteogenesis support: Strontium-substituted hydroxyapatite and SrO-doped bioglass are described as supporting cell viability and osteogenic aims via sustained ion release.

    • Antibacterial effects (materials context): SrO/MgO-doped bioglass samples showed higher antibacterial effect than standard Bioglass 45S5 in the cited work.

  • Possible broader systemic effects (less certain): One review proposes roles in mitigating aspects of non-communicable diseases via reduced oxidative stress and suppression of inflammatory cytokines, but also states evidence is incomplete and optimal intake levels are not well defined.

4. Does it have any downsides or side effects?

  • Uncertainty/controversy in mechanism and interpretation: One osteoporosis-focused review notes that how strontium ranelate improves bone strength in humans “remains a matter of debate,” which is not a side effect per se but signals scientific uncertainty.

  • Lack of benefit in dentine hypersensitivity formulations: The DH meta-analysis concluded that it does not advise strontium-containing toothpastes for DH and rated the evidence as low quality. This is a “downside” in terms of effectiveness rather than safety.

  • Radiostrontium exposure risk (environmental): The radiostrontium review highlights that radioactive strontium can enter the food chain via plant uptake and poses potential hazards—this is relevant to environmental exposure rather than supplementation, but it is a clear health risk context involving strontium isotopes.

  • Side effects/adverse events: The studies reviewed here do not describe specific clinical adverse effects (e.g., cardiovascular or thrombotic risks) or contraindications for strontium ranelate or strontium supplements. Therefore, no evidence-based side-effect summary can be made from these studies alone.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic findings (e.g., gene variants predicting response, toxicity, or dosing) for strontium ranelate, strontium ions, or strontium-containing dental/material applications.

  • No specific gene–strontium interactions are described (e.g., CaSR polymorphisms, RANKL/OPG pathway variants, transporters) in these studies.

  • As a result, based on the supplied evidence, it is unknown whether any genetic variations make strontium more beneficial or more harmful.

References

  1. The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment.
    Barbara Kołodziejska, Natalia Stępień, Joanna Kolmas (2021) - International journal of molecular sciences
  2. Honey and Health: A Review of Recent Clinical Research.
    Saeed Samarghandian, Tahereh Farkhondeh, Fariborz Samini (2017) - Pharmacognosy research
  3. Advanced applications of strontium-containing biomaterials in bone tissue engineering.
    Xiao Sheng, Chen Li, Zhonghan Wang, Yu Xu, Yang Sun, Weimin Zhang, He Liu, Jincheng Wang (2023) - Materials today. Bio
  4. Strontium in the environment: Review about reactions of plants towards stable and radioactive strontium isotopes.
    Anna Burger, Irene Lichtscheidl (2019) - The Science of the total environment
  5. Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis.
    Zuzana Saidak, Pierre J Marie (2012) - Pharmacology & therapeutics
  6. Chitosan/hydroxyapatite composite bone tissue engineering scaffolds with dual and decoupled therapeutic ion delivery: copper and strontium.
    Lukas Gritsch, Muhammad Maqbool, Viviana Mouriño, Francesca E Ciraldo, Mark Cresswell, Philip R Jackson, Christopher Lovell, Aldo R Boccaccini (2019) - Journal of materials chemistry. B
  7. Bioactive Glasses Containing Strontium or Magnesium Ions to Enhance the Biological Response in Bone Regeneration.
    Sílvia Rodrigues Gavinho, Ana Sofia Pádua, Laura Isabel Vilas Holz, Isabel Sá-Nogueira, Jorge Carvalho Silva, João Paulo Borges, Manuel Almeida Valente, Manuel Pedro Fernandes Graça (2023) - Nanomaterials (Basel, Switzerland)
  8. Microelement strontium and human health: comprehensive analysis of the role in inflammation and non-communicable diseases (NCDs).
    Xin Ru, Lida Yang, Guohui Shen, Kunzhen Wang, Zihan Xu, Wenbo Bian, Wenqi Zhu, Yanzhi Guo (2024) - Frontiers in chemistry
  9. How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis.
    P J Marie, D Felsenberg, M L Brandi (2011) - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
  10. Effect of desensitizing toothpastes on dentine hypersensitivity: A systematic review and meta-analysis.
    Meng-Long Hu, Gang Zheng, You-Dong Zhang, Xiang Yan, Xiao-Chan Li, Hong Lin (2018) - Journal of dentistry
  11. Strontium-Alix interaction enhances exosomal miRNA selectively loading in synovial MSCs for temporomandibular joint osteoarthritis treatment.
    Wenxiu Yuan, Jiaqi Liu, Zhenzhen Zhang, Chengxinyue Ye, Xueman Zhou, Yating Yi, Yange Wu, Yijun Li, Qinlanhui Zhang, Xin Xiong, Hengyi Xiao, Jin Liu, Jun Wang (2025) - International journal of oral science
  12. The effects of strontium on bone mineral: A review on current knowledge and microanalytical approaches.
    William Querido, Andre L Rossi, Marcos Farina (2016) - Micron (Oxford, England : 1993)
  13. A new insight into the dissociating effect of strontium on bone resorption and formation.
    Julien Braux, Frédéric Velard, Christine Guillaume, Sylvie Bouthors, Edouard Jallot, Jean-Marie Nedelec, Dominique Laurent-Maquin, Patrice Laquerrière (2011) - Acta biomaterialia
  14. Strontium alleviated the growth inhibition and toxicity caused by cadmium in rice seedlings.
    Jun Liu, Xinting Fan, Yuanyuan Jiang, Juan Ni, Aili Mo, Meihan Cai, Tong Li, Yaqi Wang, Peishuang He, Shiyu Hu, Tangjian Peng, Cuiying Peng, Fei Yang (2023) - The Science of the total environment
  15. Vancomycin- and Strontium-Loaded Microspheres with Multifunctional Activities against Bacteria, in Angiogenesis, and in Osteogenesis for Enhancing Infected Bone Regeneration.
    Pengfei Wei, Wei Jing, Zuoying Yuan, Yiqian Huang, Binbin Guan, Wenxin Zhang, Xu Zhang, Jianping Mao, Qing Cai, Dafu Chen, Xiaoping Yang (2019) - ACS applied materials & interfaces
  16. Effect of strontium surface-functionalized implants on early and late osseointegration: A histological, spectrometric and tomographic evaluation.
    Vincent Offermanns, Ole Z Andersen, Gregor Riede, Michael Sillassen, Christian S Jeppesen, Klaus P Almtoft, Heribert Talasz, Caroline Öhman-Mägi, Bernd Lethaus, Rene Tolba, Frank Kloss, Morten Foss (2018) - Acta biomaterialia
  17. The Efficacy and Safety of Disease-Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis-a Systematic Review and Network Meta-Analysis.
    Wei Yang, Cheng Sun, Sheng Qin He, Ji Ying Chen, Yan Wang, Qi Zhuo (2021) - Journal of general internal medicine
  18. The position of strontium ranelate in today's management of osteoporosis.
    J-Y Reginster, M-L Brandi, J Cannata-Andía, C Cooper, B Cortet, J-M Feron, H Genant, S Palacios, J D Ringe, R Rizzoli (2015) - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
  19. Cardiovascular safety of calcium, magnesium and strontium: what does the evidence say?
    Elizabeth M Curtis, Cyrus Cooper, Nicholas C Harvey (2021) - Aging clinical and experimental research
  20. Effect of bioactive glasses containing strontium and potassium on dentin permeability.
    Luisa Alegria Acevedo, Letícia Antonelo Campos, Iolanda Cristina Dechandt, Gustavo Alegria, Renato Luiz Siqueira, Edgar Dutra Zanotto, Francisco Carlos Serbena, Fabio André Santos (2022) - Journal of biomedical materials research. Part B, Applied biomaterials


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!